-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Tilray Stock Has Fallen and Can’t Get Up
Tilray stock, along with the rest of the marijuana sector, have fallen out of favor and won't get back up. They need consistent profit.
Don’t Expect Much From Aurora Cannabis Stock’s Upcoming Report
ACB stock is set to fall much further. Aurora can't make money because of lower selling prices, overspending and its huge cash burn.
3 Pros, 3 Cons for New Age Beverages Stock
NBEV stock has the potential to dominate the CBD-infused beverages market. But legal and competitive problems shouldn’t be ignored.
What to Expect From Aurora Cannabis Stock Ahead of Earnings
With much of its debt coming due in March, ACB stock will need to calm investors' worries about dilution on this quarter's earnings call.
Aphria Stock Will Reward Patient Investors
Aphria stock has declined in recent months along with its peers, but an eventual recovery by APHA should reward patient investors.
Why I Changed My Mind About Canopy Growth Stock
Canopy Growth stock is one of the four big Canadian pot companies that will report results for the quarter ended Sept. 30 this week and Street expectations aren't optimistic.
With Huge Cash Burn, Canopy Growth Stock Is Set to Fall Further
With its huge cash burn, Canopy Growth stock is set for further downside. Short sellers are raising their bets on CGC.
Healthcare Stocks: 1 Buy, 1 Sell, 1 Hold
You don't need to avoid healthcare stocks completely. Just be careful where you invest. There's one name Louis Navellier really likes in the space, for example.
High Hopes: Tilray Stock Needs a Miracle to Finish 2019 Strong
Investors justifiably have low expectations for TLRY stock ahead of quarterly earnings. Here's the outlook for Tilray through the end of 2019.
This $2.7 Billion Deal Is a Shot Across the Bow for Big Pharma
Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.
Investors Should Use Other Metrics to Evaluate Cronos Group Stock
Some believe that Cronos stock overvalued. But if you consider cash on the balance sheet, CRON stock is more than reasonable.
Even With New CEO, Debt-Laden Rite Aid Stock is Best Avoided for Near Term
RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.
Aurora Cannabis Stock Will Be Boosted by ACB’s Retail Expansion
Aurora’s medical cannabis business is strong and can boost ACB stock over time. Also likely to help Aurora stock is ACB's retail expansion.
My Misgivings About Aurora Cannabis Stock Continue to Grow
A year after legalization, things aren't looking good for ACB stock. I recommend waiting on the sidelines until vaping risks clear up.
Aurora Cannabis Stock Could Climb in the Long-Term
Like all the other marijuana stocks, ACB stock has been beaten up, but Aurora stock may have more potential than its rivals.
The Bubble Has Burst, But Tilray Stock Is More Than a Penny Stock
Tilray stock is hovering near its IPO level. The cannabis bubble has burst, but that doesn't mean TLRY should be treated like a penny stock.
Aurora Cannabis Stock Demonstrates Promising Trading Opportunities
ACB stock's trading range is tight and a move is coming. After a 60% drop, much of the fat has been shed and there are breakout lines just above.
Aurora Stock: Why It’s Worthwhile for Speculators
Like just about every other marijuana stock, ACB stock has been in bear mode. But this is creating an interesting opportunity. Here’s a look at why now might be the time to consider Aurora stock.
